June 2, 2016
…the basis for new antiviral drugs. Currently, there is no vaccine or medicine to treat Zika virus. The project will screen more than 20 million compounds from existing databases against models of Zika protein structures with dramatically more speed than in a traditional lab. UC San Diego will play a…
April 3, 2023
The National Institute of Allergy and Infectious Diseases has awarded a five-year, $15.45 million grant to the San Diego Center for AIDS Research at UC San Diego, renewing support that extends back to an original establishing grant in 1994 at the height of the AIDS epidemic.
April 7, 2020
Experts at UC San Diego are available to discuss the novel coronavirus, the COVID-19 illness and the societal impacts of the pandemic.
January 21, 2021
…the U.S. Food and Drug Administration. Erik Engelson, a UC San Diego bioengineering and microbiology alumnus, is president and CEO of Lucira Health, which was founded by UC Berkeley bioengineering alumni. The Lucira COVID-19 All-In-One Test Kit is a molecular test that uses a simple nasal swab to return results…
January 23, 2020
…the UC San Diego AntiViral Research Center to their most recent research study. In the study, published in PLOS Medicine on Oct. 4, 2019, Browne and her colleagues tested a new treatment approach called wirelessly observed therapy, or WOT. Under WOT, patients wear a small electronic patch on their skin;…
September 17, 2020
…aches. Doctors may prescribe antiviral medications, such as Tamiflu, Relenza, Rapivab or Xofluza, for persons at heightened risk. These drugs shorten the duration of illness and help prevent complications. “I highly encourage people to consult with their primary care physician so that they can receive timely medical advice, especially if…
December 15, 2022
As we look forward to the upcoming new year, UC San Diego Today invites readers to take a look back at some milestones from 2022.
